(a) Any pharmacy which sells a legend drug in violation of § 48-801.03, § 48-801.04, or § 48-801.05 is liable to the buyer, or the provider or insurer of the buyer, for the full amount charged for the drug.
(b) Civil fines, penalties, and fees may be imposed as alternative sanctions for any infraction of the provisions of this subchapter, or any rules or regulations issued under the authority of this subchapter, pursuant to Chapter 18 of Title 2. Adjudication of any infraction of this subchapter shall be pursuant to Chapter 18 of Title 2.
(Sept. 10, 1976, D.C. Law 1-81, title IV, § 401, 23 DCR 2460; Mar. 8, 1991, D.C. Law 8-237, § 20, 38 DCR 314.)
HISTORICAL AND STATUTORY NOTES
Prior Codifications
1981 Ed., § 33-741.
1973 Ed., § 33-841.
Legislative History of Laws
For legislative history of D.C. Law 1-81, see Historical and Statutory Notes following § 48-804.51.
Law 8-237 was introduced in Council and assigned Bill No. 8-203, which was referred to the Committee on Consumer and Regulatory Affairs. The Bill was adopted on first and second readings on December 4, 1990, and December 18, 1990, respectively. Signed by the Mayor on December 27, 1990, it was assigned Act No. 8-320 and transmitted to both Houses of Congress for its review.
Any person who, by any means, interferes with, prevents, discourages, or attempts to interfere with, prevent, or discourage: (1) any disclosure of, or attempt to disclose, or action necessary to disclose, substantially accurate prices, discounts, services, or other information concerning any prescription drug, whether or not such disclosure is authorized or directed in this chapter, or is through any media or other form of communication, or is made or to be made by any publisher, broadcaster, pharmacy, pharmacist, advertiser, drug manufacturer, wholesaler, or chain, government agency, or any other person; or (2) any retail drug price-setting, substitution, or marketing policy or action required, encouraged or permitted by, or consistent with this chapter; has committed a restraint of trade, and has caused a tortious injury in the District of Columbia as described in § 13-423(a)(3) and (4), and shall be liable for treble civil damages to each and every person (including a pharmacy or pharmacist), health insurer, and government agency the object of or injured by such interference, prevention, discouragement, or attempt to interfere, prevent, or discourage. Any action which jeopardizes in any way, or raises the net price of, the supply from manufacturers or wholesalers of drugs to any pharmacy, government agency, health insurer, or person providing or paying for a drug in the District may comprise such an interference, prevention, discouragement, or attempt.
(Sept. 10, 1976, D.C. Law 1-81, title IV, § 402, 23 DCR 2460.)
HISTORICAL AND STATUTORY NOTES
Prior Codifications
1981 Ed., § 33-742.
1973 Ed., § 33-842.
Legislative History of Laws
For legislative history of D.C. Law 1-81, see Historical and Statutory Notes following § 48-804.51.
After reasonable notice, the Office of Consumer Protection may inspect the pricing records and practices of any pharmacy or other person, to assure compliance with this chapter. After appropriate notice and hearing, the Office may, if it finds that any person has violated this chapter, issue a cease and desist order against continued or future violation, and such other orders as may otherwise be within powers of that Office.
(Sept. 10, 1976, D.C. Law 1-81, title IV, § 403, 23 DCR 2460.)
HISTORICAL AND STATUTORY NOTES
Prior Codifications
1981 Ed., § 33-743.
1973 Ed., § 33-843.
Legislative History of Laws
For legislative history of D.C. Law 1-81, see Historical and Statutory Notes following § 48-804.51.
